{"id":"https://openalex.org/W4415219281","doi":"https://doi.org/10.1111/jdv.70084","title":"Biologics for treatment of paediatric plaque psoriasis: A systematic review and network meta\u2010analysis","display_name":"Biologics for treatment of paediatric plaque psoriasis: A systematic review and network meta\u2010analysis","publication_year":2025,"publication_date":"2025-10-15","ids":{"openalex":"https://openalex.org/W4415219281","doi":"https://doi.org/10.1111/jdv.70084","pmid":"https://pubmed.ncbi.nlm.nih.gov/41090545"},"language":"en","primary_location":{"id":"doi:10.1111/jdv.70084","doi":"https://doi.org/10.1111/jdv.70084","is_oa":true,"landing_page_url":"https://doi.org/10.1111/jdv.70084","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdv.70084","source":{"id":"https://openalex.org/S137740113","display_name":"Journal of the European Academy of Dermatology and Venereology","issn_l":"0926-9959","issn":["0926-9959","1468-3083"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the European Academy of Dermatology and Venereology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdv.70084","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015911892","display_name":"Abdullah Ali N Aljalfan","orcid":"https://orcid.org/0000-0002-5620-6812","observed_orcids":["https://orcid.org/0000-0002-5620-6812"]},"institutions":[{"id":"https://openalex.org/I2801255774","display_name":"King Fahd Hospital of the University","ror":"https://ror.org/0230h1q47","country_code":"SA","type":"healthcare","lineage":["https://openalex.org/I2801255774"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Abdullah Ali Aljalfan","raw_affiliation_strings":["Department of Dermatology King Fahad University Hospital  Al Khobar Saudi Arabia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology King Fahad University Hospital  Al Khobar Saudi Arabia","institution_ids":["https://openalex.org/I2801255774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003679976","display_name":"Muhammad Talha Maniya","orcid":"https://orcid.org/0000-0002-9806-5755","observed_orcids":["https://orcid.org/0000-0002-9806-5755"]},"institutions":[{"id":"https://openalex.org/I923305593","display_name":"Ziauddin University","ror":"https://ror.org/03vz8ns51","country_code":"PK","type":"education","lineage":["https://openalex.org/I923305593"]}],"countries":["PK"],"is_corresponding":false,"raw_author_name":"Muhammad Talha Maniya","raw_affiliation_strings":["Department of Medicine Ziauddin University  Karachi Pakistan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine Ziauddin University  Karachi Pakistan","institution_ids":["https://openalex.org/I923305593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092383188","display_name":"Dilshad Sachedina","orcid":"https://orcid.org/0000-0002-0878-6664","observed_orcids":["https://orcid.org/0000-0002-0878-6664"]},"institutions":[{"id":"https://openalex.org/I1286490081","display_name":"Boston Medical Center","ror":"https://ror.org/010b9wj87","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1286490081"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dilshad Sachedina","raw_affiliation_strings":["Department of Dermatology Boston Medical Center  Boston Massachusetts USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology Boston Medical Center  Boston Massachusetts USA","institution_ids":["https://openalex.org/I1286490081"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068510767","display_name":"Seereen R Almuhaidib","orcid":"https://orcid.org/0000-0002-5336-3345","observed_orcids":["https://orcid.org/0000-0002-5336-3345"]},"institutions":[{"id":"https://openalex.org/I76571253","display_name":"Imam Abdulrahman Bin Faisal University","ror":"https://ror.org/038cy8j79","country_code":"SA","type":"education","lineage":["https://openalex.org/I76571253"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Serene Raaed Almuhaidib","raw_affiliation_strings":["College of Medicine Imam Abdulrahman Bin Faisal University  Dammam Saudi Arabia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Medicine Imam Abdulrahman Bin Faisal University  Dammam Saudi Arabia","institution_ids":["https://openalex.org/I76571253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101962532","display_name":"Abdulmajeed Alharbi","orcid":"https://orcid.org/0000-0002-1590-7559","observed_orcids":["https://orcid.org/0000-0002-1590-7559"]},"institutions":[{"id":"https://openalex.org/I76571253","display_name":"Imam Abdulrahman Bin Faisal University","ror":"https://ror.org/038cy8j79","country_code":"SA","type":"education","lineage":["https://openalex.org/I76571253"]}],"countries":["SA"],"is_corresponding":true,"raw_author_name":"Abdulmajeed Sulaiman Alharbi","raw_affiliation_strings":["College of Medicine Imam Abdulrahman Bin Faisal University  Dammam Saudi Arabia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Medicine Imam Abdulrahman Bin Faisal University  Dammam Saudi Arabia","institution_ids":["https://openalex.org/I76571253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049571247","display_name":"Rahmah M Alamrie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rahmah Alamrie","raw_affiliation_strings":["Dermatology Department Dammam Medical Complex  Dammam Saudi Arabia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology Department Dammam Medical Complex  Dammam Saudi Arabia","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Umna Aziz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I39727005","display_name":"Dow University of Health Sciences","ror":"https://ror.org/01h85hm56","country_code":"PK","type":"education","lineage":["https://openalex.org/I39727005"]}],"countries":["PK"],"is_corresponding":false,"raw_author_name":"Umna Aziz","raw_affiliation_strings":["Department of Medicine Dow International Medical College  Karachi Pakistan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine Dow International Medical College  Karachi Pakistan","institution_ids":["https://openalex.org/I39727005"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5104297070","display_name":"Anusha Abdul Muqeet Farid","orcid":"https://orcid.org/0009-0008-2101-8249","observed_orcids":["https://orcid.org/0009-0008-2101-8249"]},"institutions":[{"id":"https://openalex.org/I923305593","display_name":"Ziauddin University","ror":"https://ror.org/03vz8ns51","country_code":"PK","type":"education","lineage":["https://openalex.org/I923305593"]}],"countries":["PK"],"is_corresponding":false,"raw_author_name":"Anusha Abdul Muqeet Farid","raw_affiliation_strings":["Department of Medicine Ziauddin University  Karachi Pakistan"],"raw_orcid":"https://orcid.org/0009-0008-2101-8249","affiliations":[{"raw_affiliation_string":"Department of Medicine Ziauddin University  Karachi Pakistan","institution_ids":["https://openalex.org/I923305593"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5101962532"],"corresponding_institution_ids":["https://openalex.org/I76571253"],"apc_list":{"value":5450,"currency":"USD","value_usd":5450},"apc_paid":null,"fwci":0.576,"has_fulltext":true,"cited_by_count":8,"citation_normalized_percentile":{"value":0.515625,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"40","issue":"4","first_page":"597","last_page":"609"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.9929999709129333},{"id":"https://openalex.org/keywords/ixekizumab","display_name":"ixekizumab","score":0.9789999723434448},{"id":"https://openalex.org/keywords/secukinumab","display_name":"secukinumab","score":1.0},{"id":"https://openalex.org/keywords/ustekinumab","display_name":"ustekinumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pasi-response","display_name":"PASI response","score":0.8709999918937683},{"id":"https://openalex.org/keywords/dermatology-life-quality-index","display_name":"Dermatology Life Quality Index","score":0.7940000295639038},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.6370000243186951},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.8149999976158142},{"id":"https://openalex.org/keywords/comparative-effectiveness","display_name":"comparative effectiveness","score":0.49300000071525574},{"id":"https://openalex.org/keywords/moderate-to-severe-psoriasis","display_name":"moderate-to-severe psoriasis","score":0.6859999895095825},{"id":"https://openalex.org/keywords/children-and-adolescents","display_name":"children and adolescents","score":0.6840000152587891},{"id":"https://openalex.org/keywords/tnf-alpha-inhibitors","display_name":"TNF-alpha inhibitors","score":0.5809999704360962},{"id":"https://openalex.org/keywords/il-17-inhibitors","display_name":"IL-17 inhibitors","score":0.7839999794960022},{"id":"https://openalex.org/keywords/il-23-inhibitors","display_name":"IL-23 inhibitors","score":0.9110000133514404},{"id":"https://openalex.org/keywords/il-12-23-inhibitors","display_name":"IL-12/23 inhibitors","score":0.7139999866485596}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9886000156402588},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5885999798774719},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.47099998593330383},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.26489999890327454},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.26089999079704285},{"id":"https://openalex.org/C2908569021","wikidata":"https://www.wikidata.org/wiki/Q2896740","display_name":"Anti-Infective Agents","level":3,"score":0.2590000033378601},{"id":"https://openalex.org/C2911221801","wikidata":"https://www.wikidata.org/wiki/Q2742406","display_name":"Biologic Agents","level":3,"score":0.25780001282691956},{"id":"https://openalex.org/C189708586","wikidata":"https://www.wikidata.org/wiki/Q1504425","display_name":"Systematic review","level":3,"score":0.25519999861717224},{"id":"https://openalex.org/C2908856526","wikidata":"https://www.wikidata.org/wiki/Q16252627","display_name":"Antibody therapy","level":4,"score":0.22419999539852142},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.1907999962568283}],"mesh":[{"descriptor_ui":"D000069549","descriptor_name":"Ustekinumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000071076","descriptor_name":"Network Meta-Analysis as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/jdv.70084","doi":"https://doi.org/10.1111/jdv.70084","is_oa":true,"landing_page_url":"https://doi.org/10.1111/jdv.70084","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdv.70084","source":{"id":"https://openalex.org/S137740113","display_name":"Journal of the European Academy of Dermatology and Venereology","issn_l":"0926-9959","issn":["0926-9959","1468-3083"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the European Academy of Dermatology and Venereology","raw_type":"journal-article"},{"id":"pmid:41090545","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41090545","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the European Academy of Dermatology and Venereology : JEADV","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/jdv.70084","doi":"https://doi.org/10.1111/jdv.70084","is_oa":true,"landing_page_url":"https://doi.org/10.1111/jdv.70084","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdv.70084","source":{"id":"https://openalex.org/S137740113","display_name":"Journal of the European Academy of Dermatology and Venereology","issn_l":"0926-9959","issn":["0926-9959","1468-3083"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the European Academy of Dermatology and Venereology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"},{"display_name":"Meta-Analysis","id":"https://openalex.org/study-designs/meta-analysis"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4415219281.pdf","grobid_xml":"https://content.openalex.org/works/W4415219281.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W1598602811","https://openalex.org/W1617328014","https://openalex.org/W1842534514","https://openalex.org/W2033876280","https://openalex.org/W2042638001","https://openalex.org/W2111999709","https://openalex.org/W2149738389","https://openalex.org/W2168503185","https://openalex.org/W2169005742","https://openalex.org/W2324298557","https://openalex.org/W2565883611","https://openalex.org/W2610923037","https://openalex.org/W2624672837","https://openalex.org/W2766694006","https://openalex.org/W2769068226","https://openalex.org/W2942228012","https://openalex.org/W2985156506","https://openalex.org/W2989875916","https://openalex.org/W3092915044","https://openalex.org/W3110401644","https://openalex.org/W3114159040","https://openalex.org/W3133382012","https://openalex.org/W3164088949","https://openalex.org/W3199547320","https://openalex.org/W3206469927","https://openalex.org/W4200531789","https://openalex.org/W4223413518","https://openalex.org/W4235945692","https://openalex.org/W4243747196","https://openalex.org/W4282575323","https://openalex.org/W4293479344","https://openalex.org/W4361000839"],"related_works":["https://openalex.org/W4293479344","https://openalex.org/W4297252185","https://openalex.org/W7167524221","https://openalex.org/W4200219158","https://openalex.org/W4297229374","https://openalex.org/W3036523869","https://openalex.org/W3115313036","https://openalex.org/W4292326039","https://openalex.org/W3149331822","https://openalex.org/W4413934374"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1],"OBJECTIVES:":[2],"As":[3],"biologic":[4,34,157,224,244],"therapy":[5],"is":[6],"increasingly":[7],"being":[8],"utilized":[9],"in":[10,52,91,97,103,174,284],"the":[11,28,68,71,169,176,188,198,208,247,279,289],"treatment":[12,248,291],"of":[13,32,85,109,124,249],"paediatric":[14,40,251],"psoriasis,":[15],"we":[16],"aim":[17],"to":[18,26,38,142,154,236,287],"perform":[19],"a":[20,61,88,160,258,261,268],"systematic":[21],"review":[22],"and":[23,30,57,78,116,164,207,231,255,273],"network":[24,64],"meta-analysis":[25,65],"compare":[27],"efficacy":[29],"safety":[31,117],"available":[33],"treatments":[35],"for":[36,51,77,190,246,281],"moderate":[37],"severe":[39],"plaque":[41,252],"psoriasis.":[42,253],"METHODS:":[43],"Relevant":[44],"randomized":[45],"controlled":[46],"trials":[47,283],"(RCTs)":[48],"were":[49,87,126,151,233],"searched":[50],"PubMed,":[53],"Embase,":[54],"Cochrane":[55],"CENTRAL":[56],"clinicaltrials.gov.":[58],"We":[59],"performed":[60],"fixed-effects":[62],"frequentist":[63],"(NMA)":[66],"with":[67,137,238],"surface":[69],"under":[70],"cumulative":[72],"ranking":[73,80],"curve":[74],"(SUCRA)":[75],"calculated":[76],"mean":[79],"calculated.":[81],"The":[82],"main":[83],"outcomes":[84,118],"interest":[86],"\u226575%":[89],"improvement":[90,96,102],"PASI":[92,98,104],"score":[93,99,105,108],"(PASI75),":[94],"\u226590%":[95],"(PASI90),":[100],"100%":[101],"(PASI100),":[106],"CDLQI":[107,199,272],"0/1":[110,200],"(CDLQI":[111],"0/1)":[112],"at":[113,119],"weeks":[114],"12-16":[115],"12-20":[120],"weeks.":[121],"Point":[122],"probabilities":[123],"response":[125,206],"also":[127],"calculated,":[128],"presented":[129],"as":[130],"absolute":[131],"risk":[132],"differences":[133],"per":[134],"1000":[135],"patients":[136,150],"their":[138],"95%":[139],"CIs":[140],"compared":[141],"placebo.":[143],"RESULTS:":[144],"Seven":[145],"RCTs":[146],"comprising":[147],"1016":[148],"psoriasis":[149],"included.":[152],"Compared":[153],"placebo,":[155,237],"all":[156],"therapies":[158],"exhibited":[159,219],"significantly":[161,234],"higher":[162,262],"PASI90":[163,191,263],"PASI75":[165,209,274],"response.":[166,183],"Based":[167],"on":[168],"SUCRA,":[170],"Ixekizumab":[171,254],"ranked":[172,187],"highest":[173],"achieving":[175],"PASI100":[177],"(SUCRA:":[178,192,201,210],"0.9,":[179,211],"Mean":[180,194,203,212],"Rank:":[181,195,204,213],"1.8)":[182],"Secukinumab":[184,256],"high":[185],"dose":[186,217],"best":[189],"0.8,":[193,202],"3.0).":[196],"For":[197],"2.2)":[205,214],"response,":[215,264],"standard":[216],"Ustekinumab":[218,266],"superior":[220,235],"performance.":[221],"CONCLUSIONS:":[222],"All":[223],"agents":[225],"(not":[226],"including":[227],"non-biologic":[228],"comparators":[229],"methotrexate":[230],"FAEs)":[232],"no":[239],"significant":[240],"difference":[241],"between":[242],"individual":[243],"therapies,":[245],"moderate-to-severe":[250],"demonstrated":[257],"trend":[259,269],"towards":[260,270],"while":[265],"showed":[267],"increased":[271],"responses.":[275],"These":[276],"findings":[277],"highlight":[278],"need":[280],"better-powered":[282],"this":[285],"population":[286],"determine":[288],"optimal":[290],"modality.":[292],"PROSPERO":[293],"NUMBER:":[294],"CRD42023476983.":[295]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2025-10-16T00:00:00"}